Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Eunice Jin Hui Goh, Ikhwanuliman Putera, Rina La Distia Nora, Padmamalini Mahendradas, Jyotirmay Biswas, Soon-Phaik Chee, Ilaria Testi, Carlos E Pavesio, Andre Luiz Land Curi, Daniel Vitor Vasconcelos-Santos, Atul Arora, Vishali Gupta, Alejandra de-la-Torre & Rupesh Agrawal. (2023) Ocular Toxoplasmosis. Ocular Immunology and Inflammation 31:7, pages 1342-1361.
Read now
Read now
Paulo Tadashi Shimokawa, Lília Spaleta Targa, Lidia Yamamoto, Jonatas Cristian Rodrigues, Kelly Aparecida Kanunfre & Thelma Suely Okay. (2016) HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis. Virulence 7:4, pages 456-464.
Read now
Read now
Eskild Petersen. (2007) Prevention and treatment of congenital toxoplasmosis. Expert Review of Anti-infective Therapy 5:2, pages 285-293.
Read now
Read now
Eskild Petersen & Dorte Remmer Schmidt. (2003) Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?. Expert Review of Anti-infective Therapy 1:1, pages 175-182.
Read now
Read now
Articles from other publishers (77)
Mehul Chorawala, Nirjari Kothari, Aayushi Shah, Aanshi Pandya, Ishika Shah & Bhupendra G. Prajapati. 2024. Rising Contagious Diseases. Rising Contagious Diseases
314
336
.
Laurent Mandelbrot & Jorge Enrique Gomez-Marin. 2024. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
MARIAN G. MICHAELS, PABLO J. SÁNCHEZ & PHILANA LING LIN. 2024. Avery's Diseases of the Newborn. Avery's Diseases of the Newborn
487
511.e7
.
Zahra Abbasali, Majid Pirestani, Abdolhossein Dalimi, Milad Badri & Mahdi Fasihi-Ramandi. (2023) Anti-parasitic activity of a chimeric peptide Cecropin A (2−8)-Melittin (6−9) (CM11) against tachyzoites of Toxoplasma gondii and the BALB/c mouse model of acute toxoplasmosis. Molecular and Biochemical Parasitology 255, pages 111578.
Crossref
Crossref
Aryani Felixa Fajardo Martínez, Samuel Cota Teixeira, Guilherme de Souza, Alessandra Monteiro Rosini, Joed Pires de Lima Júnior, Gabriel Nogueira Melo, Kelvin Orlando Espinoza Blandón, Angelica Oliveira Gomes, Sergio Ricardo Ambrósio, Rodrigo Cassio Sola Veneziani, Jairo Kenupp Bastos, Carlos Henrique Gomes Martins, Eloisa Amália Vieira Ferro & Bellisa Freitas Barbosa. (2023) Leaf hydroalcoholic extract and oleoresin from Copaifera multijuga control Toxoplasma gondii infection in human trophoblast cells and placental explants from third-trimester pregnancy. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
Despina G. Contopoulos-Ioannidis & Jose G. Montoya. 2023. Principles and Practice of Pediatric Infectious Diseases. Principles and Practice of Pediatric Infectious Diseases
1384
1399.e4
.
Justus G. Garweg, François Kieffer, Laurent Mandelbrot, François Peyron & Martine Wallon. (2022) Long-Term Outcomes in Children with Congenital Toxoplasmosis—A Systematic Review. Pathogens 11:10, pages 1187.
Crossref
Crossref
Majid Pirestani, Hossein Sobati & Ali Dalir Ghaffari. (2022) Investigation of Antiparasitic Effects of Eisenia fetida Extract (Annelida, Lumbricidae) against Toxoplasma gondii: In vitro Study. Current Traditional Medicine 8:5.
Crossref
Crossref
Gabriella de Lima Bessa, Ricardo Wagner de Almeida Vitor & Erica dos Santos Martins-Duarte. (2021) Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations. Parasitology Research 120:9, pages 3065-3076.
Crossref
Crossref
Hafiz Muhammad Rizwan, Haider Abbas, Muhammad Sohail Sajid, Mahvish Maqbool, Malcolm K. Jones, Muhammad Irfan Ullah & Nabeel Ijaz. 2021. Biochemistry of Drug Resistance. Biochemistry of Drug Resistance
95
142
.
Samuel Cota Teixeira, Guilherme de Souza, Bruna Cristina Borges, Thádia Evelyn de Araújo, Alessandra Monteiro Rosini, Fábio Alves Aguila, Sergio Ricardo Ambrósio, Rodrigo Cassio Sola Veneziani, Jairo Kenupp Bastos, Marcelo José Barbosa Silva, Carlos Henrique Gomes Martins, Bellisa de Freitas Barbosa & Eloisa Amália Vieira Ferro. (2020) Copaifera spp. oleoresins impair Toxoplasma gondii infection in both human trophoblastic cells and human placental explants. Scientific Reports 10:1.
Crossref
Crossref
Olivier Picone, Florent Fuchs, Guillaume Benoist, Christine Binquet, François Kieffer, Martine Wallon, Karl Wehbe, Laurent Mandelbrot & Isabelle Villena. (2020) Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF. Journal of Gynecology Obstetrics and Human Reproduction 49:7, pages 101814.
Crossref
Crossref
Neda Konstantinovic, Hélène Guegan, Tijana Stäjner, Sorya Belaz & Florence Robert-Gangneux. (2019) Treatment of toxoplasmosis: Current options and future perspectives. Food and Waterborne Parasitology 15, pages e00036.
Crossref
Crossref
Isabelle Villena & Laurence Lachaud. (2019) Toxoplasmose et grossesse. Revue Francophone des Laboratoires 2019:509, pages 52-59.
Crossref
Crossref
Mahbobeh Montazeri, Saeed Mehrzadi, Mehdi Sharif, Shahabeddin Sarvi, Asal Tanzifi, Sargis A. Aghayan & Ahmad Daryani. (2018) Drug Resistance in Toxoplasma gondii. Frontiers in Microbiology 9.
Crossref
Crossref
Laurent Mandelbrot, François Kieffer, Rémi Sitta, Hélène Laurichesse-Delmas, Norbert Winer, Louis Mesnard, Alain Berrebi, Gwenaëlle Le Bouar, Jean-Paul Bory, Anne-Gaëlle Cordier, Yves Ville, Franck Perrotin, Jean-Marie Jouannic, Florence Biquard, Claude d’Ercole, Véronique Houfflin-Debarge, Isabelle Villena, Rodolphe Thiébaut, Hélène Laurichesse-Delmas, Denis Pons, C. Nourrisson, Norbert Winer, Rose-Anne Lavergne, Alain Berrebi, Judith Fillaux, Corinne Assouline, Louis Mesnard, Isabelle Villena, Jean-Paul Bory, Gwenaëlle Le Bouar, Florence Robert-Gangneux, Claude d’Ercole, Coralie L’Ollivier, Florence Bretelle, Béatrice Guidicelli, Patricia Garcia, Anne-Gaelle Cordier, Alexandra Benachi, Christelle Vauloup-Fellous, Emmanuelle Letamendia, Yves Ville, Marie-Elisabeth Bougnoux, Franck Perrotin, Nathalie Van Langendonck, Jérôme Potin, Pierre Marty, Christelle Pomarès, Cynthia Trastour, Véronique Houfflin-Debarge, Anne Sophie Deleplancque, François Kieffer, Jean-Marie Jouannic, Jean-Marc Costa, Marie-Thérèse Chève, Jean-Yves Col, Florence Biquard, Bernard Cimon, Y. Sterkers, Laurence Lachaud, Gilles Burlet, Martine Maréchaud, Estelle Perraud, Anne-Gaelle Grébille, Morgane Valentin, Sandrine Houzé, Sophie Omnès, Yvon Chitrit, Christine Boissinot, Hélène Yéra, Olivia Anselem, Vassilis Tsatsaris, Marie-Victoire Sénat, Florent Fuchs, Adela Angoulvant, Charles Muszynski, Anne Totet, Catherine Noël, Laurent Bidat, Tiphaine Barjat, Pierre Flori, Hervé Pelloux, Marie-Pierre Brenier-Pinchart, Catherine Thong-Vanh, Laurent Mandelbrot, Corinne Floch, Lionel Carbillon, Eric Lachassine, Aude Ricbourg, Luc Paris, Marc Dommergues, Thierry Rousseau, Frederic Dalle, Marie Laure Dardé, Véronique Aubard, Camille Olivier, Eric Verspyk & Loic Favennec. (2018) Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial. American Journal of Obstetrics and Gynecology 219:4, pages 386.e1-386.e9.
Crossref
Crossref
Juliana de A. Portes, Nathália F. B. Azeredo, Pedro G. T. Siqueira, Tatiana Guinancio de Souza, Christiane Fernandes, Adolfo HornJrJr, Dalber R. S. Candela, Wanderley de Souza, Renato A. DaMatta & Sérgio H. Seabra. (2018) A new iron(III) complex-containing sulfadiazine inhibits the proliferation and induces cystogenesis of Toxoplasma gondii. Parasitology Research 117:9, pages 2795-2805.
Crossref
Crossref
Juan Gabriel Costa & María Julia Vilariño. (2018) Semiquantitative Dot Blot with the GRA8 antigen to differentiate the stages of toxoplasmosis infection. Journal of Microbiological Methods 149, pages 9-13.
Crossref
Crossref
Marian G. Michaels, Pablo Sanchez & P. Ling Lin. 2018. Avery's Diseases of the Newborn. Avery's Diseases of the Newborn
527
552.e6
.
Ruben R. Ben-Harari, Elizabeth Goodwin & Julio Casoy. (2017) Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review. Drugs in R&D 17:4, pages 523-544.
Crossref
Crossref
Rafaela J. da Silva, Angelica O. Gomes, Priscila S. Franco, Ariane S. Pereira, Iliana C. B. Milian, Mayara Ribeiro, Paolo Fiorenzani, Maria C. dos Santos, José R. Mineo, Neide M. da Silva, Eloisa A. V. Ferro & Bellisa de Freitas Barbosa. (2017) Enrofloxacin and Toltrazuril Are Able to Reduce Toxoplasma gondii Growth in Human BeWo Trophoblastic Cells and Villous Explants from Human Third Trimester Pregnancy. Frontiers in Cellular and Infection Microbiology 7.
Crossref
Crossref
Cathy Chemla & Isabelle Villena. (2017) Sulfadoxine–Pyrimethamine Combination in Congenital Toxoplasmosis. Pediatric Infectious Disease Journal 36:3, pages 349-350.
Crossref
Crossref
Eskild Petersen, Daniel Ajzenberg, Laurent Mandelbrot & Jorge Enrique Gomez-Marin. 2017. International Encyclopedia of Public Health. International Encyclopedia of Public Health
114
132
.
Alexandre Mzabi, Dominique Aubert & Isabelle Villena. 2017. Antimicrobial Drug Resistance. Antimicrobial Drug Resistance
677
684
.
Juan Gabriel Costa & Andrea Belén Duré. (2016) Immunochemical evaluation of two Toxoplasma gondii GRA8 sequences to detect acute toxoplasmosis infection. Microbial Pathogenesis 100, pages 229-236.
Crossref
Crossref
Julie Teil, Damien Dupont, Bruno Charpiat, Stéphane Corvaisier, Thierry Vial, Gilles Leboucher, Martine Wallon & François Peyron. (2016) Treatment of Congenital Toxoplasmosis. The Pediatric Infectious Disease Journal 35:6, pages 634-638.
Crossref
Crossref
Marco De León-Nava, Eunice Romero-Núñez, Angélica Luna-Nophal, Johanna Bernáldez-Sarabia, Liliana Sánchez-Campos, Alexei Licea-Navarro, Jorge Morales-Montor & Saé Muñiz-Hernández. (2016) In Vitro Effect of the Synthetic cal14.1a Conotoxin, Derived from Conus californicus, on the Human Parasite Toxoplasma gondii. Marine Drugs 14:4, pages 66.
Crossref
Crossref
F. Baquero-Artigao, F. del Castillo Martín, I. Fuentes Corripio, A. Goncé Mellgren, C. Fortuny Guasch, M. de la Calle Fernández-Miranda, M.I. González-Tomé, J.A. Couceiro Gianzo, O. Neth & J.T. Ramos Amador. (2013) Guía de la Sociedad Española de Infectología Pediátrica para el diagnóstico y tratamiento de la toxoplasmosis congénita. Anales de Pediatría 79:2, pages 116.e1-116.e16.
Crossref
Crossref
Christelle Doliwa, Sandie Escotte-Binet, Dominique Aubert, Virginie Sauvage, Frédéric Velard, Aline Schmid & Isabelle Villena. (2013)
Sulfadiazine resistance in
Toxoplasma gondii
: no involvement of overexpression or polymorphisms in genes of therapeutic targets and ABC transporters
. Parasite 20, pages 19.
Crossref
Crossref
Yan-Mei Liu, Kanyin E. Zhang, Yun Liu, Hai-Chen Zhang, Yun-Xiao Song, Hua-Hua Pu, Chuan Lu, Gang-Yi Liu, Jing-Ying Jia, Qing-Si Zheng, Jian-Min Zhu & Chen Yu. (2012) Pharmacokinetic Properties and Bioequivalence of Two Sulfadoxine/Pyrimethamine Fixed-Dose Combination Tablets: A Parallel-Design Study in Healthy Chinese Male Volunteers. Clinical Therapeutics 34:11, pages 2212-2220.
Crossref
Crossref
Coralie L'Ollivier, Martine Wallon, Benoit Faucher, Renaud Piarroux, François Peyron & Jacqueline Franck. (2012) Comparison of Mother and Child Antibodies That Target High-Molecular-Mass Toxoplasma gondii Antigens by Immunoblotting Improves Neonatal Diagnosis of Congenital Toxoplasmosis. Clinical and Vaccine Immunology 19:8, pages 1326-1328.
Crossref
Crossref
Jack S. Remington, Rima McLeod, Christopher B. Wilson & George Desmonts. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
918
1041
.
Alain Berrébi, Corinne Assouline, Marie-Hélène Bessières, Myriam Lathière, Sophie Cassaing, Vincent Minville & Jean-Marc Ayoubi. (2010) Long-term outcome of children with congenital toxoplasmosis. American Journal of Obstetrics and Gynecology 203:6, pages 552.e1-552.e6.
Crossref
Crossref
DUPADAHALLI KOTRESHA & RAHMAH NOORDIN. (2010) Recombinant proteins in the diagnosis of toxoplasmosis. APMIS 118:8, pages 529-542.
Crossref
Crossref
Patricia Garcia-Méric, Jacqueline Franck, Henri Dumon & Renaud Piarroux. (2010) Prise en charge de la toxoplasmose congénitale en France : données actuelles. La Presse Médicale 39:5, pages 530-538.
Crossref
Crossref
E. Delair & A.P. Brézin. 2010. Les Uvéites. Les Uvéites
201
219
.
Geneviève Chêne & Rodolphe Thiébaut. (2009) Options for clinical trials of pre and post-natal treatments for congenital toxoplasmosis. Memórias do Instituto Oswaldo Cruz 104:2, pages 299-304.
Crossref
Crossref
Aline Schmid, Virginie Sauvage, Sandie Escotte-Binet, Dominique Aubert, Christine Terryn, Roselyne Garnotel & Isabelle Villena. (2009) Molecular characterization and expression analysis of a P-glycoprotein homologue in Toxoplasma gondii. Molecular and Biochemical Parasitology 163:1, pages 54-60.
Crossref
Crossref
Florence Robert‐Gangneux, Chantal Bourhis, Sylviane Chevrier & Jean‐Pierre Gangneux. (2009)
Evaluation of DPC immulite 2000
®
Toxoplasma
quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000
®
. Journal of Clinical Laboratory Analysis 23:5, pages 336-340.
Crossref
Crossref
E. Tridapalli, MG Capretti, G Farneti, A Marangoni, R Cevenini & G Faldella. (2008) Congenital toxoplasmosis: the importance of the western blot method to avoid unnecessary therapy in potentially infected newborns. Acta Paediatrica 97:9, pages 1298-1300.
Crossref
Crossref
Adriana Calderaro, Giovanna Piccolo, Simona Peruzzi, Chiara Gorrini, Carlo Chezzi & Giuseppe Dettori. (2008)
Evaluation of
Toxoplasma gondii
Immunoglobulin G (IgG) and IgM Assays Incorporating the New Vidia Analyzer System
. Clinical and Vaccine Immunology 15:7, pages 1076-1079.
Crossref
Crossref
Marie-Hélène Bessières, Sophie Cassaing, Judith Fillaux & Alain Berrebi. (2008) Toxoplasmose et grossesse. Revue Francophone des Laboratoires 2008:402, pages 39-50.
Crossref
Crossref
H.M. Elsheikha. (2008) Congenital toxoplasmosis: Priorities for further health promotion action. Public Health 122:4, pages 335-353.
Crossref
Crossref
François Kieffer, Martine Wallon, Patricia Garcia, Philippe Thulliez, François Peyron & Jacqueline Franck. (2008) Risk Factors for Retinochoroiditis During the First 2 Years of Life in Infants With Treated Congenital Toxoplasmosis. Pediatric Infectious Disease Journal 27:1, pages 27-32.
Crossref
Crossref
E. Petersen, R. Salmi, G. Chêne, R. Thiébaut & R. Gilbert. 2008. International Encyclopedia of Public Health. International Encyclopedia of Public Health
382
394
.
Eskild Petersen. (2007) Toxoplasmosis. Seminars in Fetal and Neonatal Medicine 12:3, pages 214-223.
Crossref
Crossref
Philip J Peters, Michael C Thigpen, Monica E Parise & Robert D Newman. (2007) Safety and Toxicity of Sulfadoxine/Pyrimethamine. Drug Safety 30:6, pages 481-501.
Crossref
Crossref
Jean-Pierre Gangneux & Florence Robert-Gangneux. (2006) Les infections parasitaires du système des phagocytes mononucléés. Revue Francophone des Laboratoires 2006:385, pages 57-68.
Crossref
Crossref
A. Sensini. (2006) Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clinical Microbiology and Infection 12:6, pages 504-512.
Crossref
Crossref
I. Villena, D. Aubert & J.-M. Pinon. (2006) Interactions cellules-hôtes-parasites : biodiversité, pathogénie, environnement. Annales Pharmaceutiques Françaises 64:2, pages 115-120.
Crossref
Crossref
Bernard Fortier, Anne Dao & Fayza Ajana. (2006) Toxoplasme et toxoplasmoses. EMC - Pédiatrie - Maladies infectieuses 1:1, pages 1-13.
Crossref
Crossref
Jack S. Remington, Rima McLeod, Philippe Thulliez & George Desmonts. 2006. Infectious Diseases of the Fetus and Newborn Infant. Infectious Diseases of the Fetus and Newborn Infant
947
1091
.
Dorte Remmer Schmidt, Birthe Hogh, Ole Andersen, Steen Honoré Hansen, Kim Dalhoff & Eskild Petersen. (2005) Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine. European Journal of Pediatrics 165:1, pages 19-25.
Crossref
Crossref
Wilma Buffolano, Elisa Beghetto, Mariassunta Del Pezzo, Andrea Spadoni, Manlio Di Cristina, Eskild Petersen & Nicola Gargano. (2005) Use of Recombinant Antigens for Early Postnatal Diagnosis of Congenital Toxoplasmosis. Journal of Clinical Microbiology 43:12, pages 5916-5924.
Crossref
Crossref
C. Chemla, I. Villena, T. Trenque, J.-M. Pinon & J.-M. Pinon. (2005) Effets secondaires du traitement anténatal de la toxoplasmose congénitale. La Presse Médicale 34:22, pages 1719.
Crossref
Crossref
T. Trenque, N. Simon, I. Villena, C. Chemla, C. Quereux, B. Leroux, R. Jaussaud, G. Rémy, D. Dupouy, H. Millart, J.‐M. Pinon & S. Urien. (2004) Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis. British Journal of Clinical Pharmacology 57:6, pages 735-741.
Crossref
Crossref
M. Breugelmans, A. Naessens & W. Foulon. (2004) Prevention of toxoplasmosis during pregnancy – an epidemiologic survey over 22 consecutive years. Journal of Perinatal Medicine 32:3.
Crossref
Crossref
Bernard Fortier, Anne Dao & Fayza Ajana. (2004) Toxoplasme et toxoplasmoses. EMC - Maladies infectieuses 1:1, pages 1-13.
Crossref
Crossref
Antoine P Brézin & Emmanuelle Delair-Briffod. (2004) Toxoplasmose oculaire. EMC - Ophtalmologie 1:1, pages 1-14.
Crossref
Crossref
F. Foudrinier, I. Villena, R. Jaussaud, D. Aubert, C. Chemla, F. Martinot & J. M. Pinon. (2003) Clinical Value of Specific Immunoglobulin E Detection by Enzyme-Linked Immunosorbent Assay in Cases of Acquired and Congenital Toxoplasmosis. Journal of Clinical Microbiology 41:4, pages 1681-1686.
Crossref
Crossref
V. Rilling, K. Dietz, D. Krczal, F. Knotek & G. Enders. (2003) Evaluation of a Commercial IgG/IgM Western Blot Assay for Early Postnatal Diagnosis of Congenital Toxoplasmosis. European Journal of Clinical Microbiology and Infectious Diseases 22:3, pages 174-180.
Crossref
Crossref
F Kieffer, P Thulliez, A Brézin, R Nobre, S Romand, E Yi-Gallimard, M Voyer & J.F Magny. (2002) Traitement de la toxoplasmose congénitale non sévère par sulfadiazine et pyriméthamine en continu pendant un an : à propos de 46 cas. Archives de Pédiatrie 9:1, pages 7-13.
Crossref
Crossref
S Kahi, G J N Cozon, J M Pinon, T Greenland, M Wallon, M Al Kurdi, J Ferrandiz & F Peyron. (1999) A switch towards Th2 during serological rebound in children with congenital toxoplasmosis. Clinical and Experimental Immunology 117:3, pages 524-528.
Crossref
Crossref
J. M. Pinon, H. Dumon, C. Chemla, J. Franck, E. Petersen, M. LebechJ. ZuffereyM.-H. Bessieres, P. Marty, R. Holliman, J. Johnson, V. Luyasu, B. Lecolier, E. GuyD. H. M. JoynsonA. Decoster, G. Enders, H. Pelloux & E. Candolfi. (2001) Strategy for Diagnosis of Congenital Toxoplasmosis: Evaluation of Methods Comparing Mothers and Newborns and Standard Methods for Postnatal Detection of Immunoglobulin G, M, and A Antibodies. Journal of Clinical Microbiology 39:6, pages 2267-2271.
Crossref
Crossref
Sylvia Siegfried Gagne. (2001) Toxoplasmosis. Primary Care Update for OB/GYNS 8:3, pages 122-126.
Crossref
Crossref
Pierre Ambroise-Thomas, Michel Schweitzer, Olivier Thiebaugeorges & Jean-Michel Schweitzer. (2001) La prévention de la toxoplasmose congénitale en France. Évaluation des risques. Résultats et perspectives du dépistage anténatal et du suivi du nouveau-né. Bulletin de l'Académie Nationale de Médecine 185:4, pages 665-688.
Crossref
Crossref
Eskild Petersen, Arnold Pollak & Ingrid Reiter-Owona. (2001) Recent trends in research on congenital toxoplasmosis. International Journal for Parasitology 31:2, pages 115-144.
Crossref
Crossref
Walter Foulon, Anne Naessens & Darrel Ho-Yen. (2000) Prevention of congenital toxoplasmosis. Journal of Perinatal Medicine 28:5.
Crossref
Crossref
Olgica Djurkovic-Djakovic, Stéphane Romand, Roberto Nobrè, Jacques Couvreur & Philippe Thulliez. (2000) SEROLOGIC REBOUNDS AFTER ONE-YEAR-LONG TREATMENT FOR CONGENITAL TOXOPLASMOSIS. The Pediatric Infectious Disease Journal 19:1, pages 81-83.
Crossref
Crossref
B. Fortier, A. Dao & F. Ajana. (2000) Toxoplasma y toxoplasmosis. EMC - Pediatría 35:3, pages 1-12.
Crossref
Crossref
F. Derouin. 2000. Congenital toxoplasmosis. Congenital toxoplasmosis
95
110
.
R. McLeod & K. Boyer. 2000. Congenital toxoplasmosis. Congenital toxoplasmosis
189
213
.
M. Hayde & A. Pollak. 2000. Congenital toxoplasmosis. Congenital toxoplasmosis
153
164
.
B. Stray-Pedersen & W. Foulon. 2000. Congenital toxoplasmosis. Congenital toxoplasmosis
141
152
.
Anne Naessens, Pål A. Jenum, Arnold Pollak, Anne Decoster, Maija Lappalainen, Isabelle Villena, Morten Lebech, Babill Stray-Pedersen, Michael Hayde, Jean-Michel Pinon, Eskild Petersen & Walter Foulon. (1999) Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation. The Journal of Pediatrics 135:6, pages 714-719.
Crossref
Crossref
I. Villena, D. Aubert, V. Brodard, C. Quereux, B. Leroux, D. Dupouy, G. Remy, F. Foudrinier, C. Chemla, J. E. Gomez-Marin & J. M. Pinon. (1999) Detection of Specific Immunoglobulin E during Maternal, Fetal, and Congenital Toxoplasmosis. Journal of Clinical Microbiology 37:11, pages 3487-3490.
Crossref
Crossref
Morten Lebech, Ole Andersen, Niels Christian Christensen, Jens Hertel, Hans Erik Nielsen, Birgit Peitersen, Catherine Rechnitzer, Severin Olesen Larsen, Bent Nørgaard-Pedersen & Eskild Petersen. (1999) Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. The Lancet 353:9167, pages 1834-1837.
Crossref
Crossref